Cytotect CP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cytotect CP, covering 2025-09-30 to 2025-09-30. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation. [Phase 2]